About Bacilligen

Bacilligen, Inc. is a privately-held, early-stage biotechnology company developing vaccines infectious diseases indications and improved technology for biological manufacturing. Founded in 2006, Bacilligen occupies lab and office space in Rockville, Maryland. The Company’s lead products include an influenza vaccine based upon a novel vaccine vector called BVS which offers unique speed, safety and cost advantages over existing vaccine technologies, especially in emergency preparedness.